心血管

订阅

MedSci主页 / 所有栏目 / 心血管

一图教你学会如何阅读冠脉CTA！

2022-02-10 心在线/新浪微博@有态度的心内科医生 心在线/新浪微博@有态度的心内科医生

冠脉CTA
关注

一图读懂！

图片

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1850146, encodeId=81fc18501464b, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Thu Aug 25 19:29:30 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195281, encodeId=737e1195281d3, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6de91548468, createdName=qingbao2004, createdTime=Sun Feb 20 09:48:45 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193148, encodeId=312c119314800, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75fb3710079, createdName=13502a13m11暂无昵称, createdTime=Sun Feb 13 23:11:19 CST 2022, time=2022-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493777, encodeId=10131493e77ad, content=<a href='/topic/show?id=3dd430933df' target=_blank style='color:#2F92EE;'>#冠脉CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30933, encryptionId=3dd430933df, topicName=冠脉CTA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=631f9090927, createdName=tcm102hq, createdTime=Sat Feb 12 01:29:30 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630069, encodeId=47491630069d4, content=<a href='/topic/show?id=6439309329e' target=_blank style='color:#2F92EE;'>#冠脉CT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30932, encryptionId=6439309329e, topicName=冠脉CT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e3821444802, createdName=许安, createdTime=Sat Feb 12 01:29:30 CST 2022, time=2022-02-12, status=1, ipAttribution=)]
    2022-08-25 windight

    #CTA#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1850146, encodeId=81fc18501464b, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Thu Aug 25 19:29:30 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195281, encodeId=737e1195281d3, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6de91548468, createdName=qingbao2004, createdTime=Sun Feb 20 09:48:45 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193148, encodeId=312c119314800, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75fb3710079, createdName=13502a13m11暂无昵称, createdTime=Sun Feb 13 23:11:19 CST 2022, time=2022-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493777, encodeId=10131493e77ad, content=<a href='/topic/show?id=3dd430933df' target=_blank style='color:#2F92EE;'>#冠脉CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30933, encryptionId=3dd430933df, topicName=冠脉CTA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=631f9090927, createdName=tcm102hq, createdTime=Sat Feb 12 01:29:30 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630069, encodeId=47491630069d4, content=<a href='/topic/show?id=6439309329e' target=_blank style='color:#2F92EE;'>#冠脉CT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30932, encryptionId=6439309329e, topicName=冠脉CT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e3821444802, createdName=许安, createdTime=Sat Feb 12 01:29:30 CST 2022, time=2022-02-12, status=1, ipAttribution=)]
    2022-02-20 qingbao2004

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1850146, encodeId=81fc18501464b, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Thu Aug 25 19:29:30 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195281, encodeId=737e1195281d3, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6de91548468, createdName=qingbao2004, createdTime=Sun Feb 20 09:48:45 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193148, encodeId=312c119314800, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75fb3710079, createdName=13502a13m11暂无昵称, createdTime=Sun Feb 13 23:11:19 CST 2022, time=2022-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493777, encodeId=10131493e77ad, content=<a href='/topic/show?id=3dd430933df' target=_blank style='color:#2F92EE;'>#冠脉CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30933, encryptionId=3dd430933df, topicName=冠脉CTA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=631f9090927, createdName=tcm102hq, createdTime=Sat Feb 12 01:29:30 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630069, encodeId=47491630069d4, content=<a href='/topic/show?id=6439309329e' target=_blank style='color:#2F92EE;'>#冠脉CT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30932, encryptionId=6439309329e, topicName=冠脉CT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e3821444802, createdName=许安, createdTime=Sat Feb 12 01:29:30 CST 2022, time=2022-02-12, status=1, ipAttribution=)]
    2022-02-13 13502a13m11暂无昵称

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1850146, encodeId=81fc18501464b, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Thu Aug 25 19:29:30 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195281, encodeId=737e1195281d3, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6de91548468, createdName=qingbao2004, createdTime=Sun Feb 20 09:48:45 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193148, encodeId=312c119314800, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75fb3710079, createdName=13502a13m11暂无昵称, createdTime=Sun Feb 13 23:11:19 CST 2022, time=2022-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493777, encodeId=10131493e77ad, content=<a href='/topic/show?id=3dd430933df' target=_blank style='color:#2F92EE;'>#冠脉CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30933, encryptionId=3dd430933df, topicName=冠脉CTA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=631f9090927, createdName=tcm102hq, createdTime=Sat Feb 12 01:29:30 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630069, encodeId=47491630069d4, content=<a href='/topic/show?id=6439309329e' target=_blank style='color:#2F92EE;'>#冠脉CT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30932, encryptionId=6439309329e, topicName=冠脉CT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e3821444802, createdName=许安, createdTime=Sat Feb 12 01:29:30 CST 2022, time=2022-02-12, status=1, ipAttribution=)]
    2022-02-12 tcm102hq

    #冠脉CTA#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1850146, encodeId=81fc18501464b, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Thu Aug 25 19:29:30 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195281, encodeId=737e1195281d3, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6de91548468, createdName=qingbao2004, createdTime=Sun Feb 20 09:48:45 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193148, encodeId=312c119314800, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75fb3710079, createdName=13502a13m11暂无昵称, createdTime=Sun Feb 13 23:11:19 CST 2022, time=2022-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493777, encodeId=10131493e77ad, content=<a href='/topic/show?id=3dd430933df' target=_blank style='color:#2F92EE;'>#冠脉CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30933, encryptionId=3dd430933df, topicName=冠脉CTA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=631f9090927, createdName=tcm102hq, createdTime=Sat Feb 12 01:29:30 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630069, encodeId=47491630069d4, content=<a href='/topic/show?id=6439309329e' target=_blank style='color:#2F92EE;'>#冠脉CT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30932, encryptionId=6439309329e, topicName=冠脉CT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e3821444802, createdName=许安, createdTime=Sat Feb 12 01:29:30 CST 2022, time=2022-02-12, status=1, ipAttribution=)]
    2022-02-12 许安

    #冠脉CT#

    0

相关资讯

JACC：CTA联合 CTP用于动态心肌灌注成像能显著提高诊断性能

与单独的CTA相比，将冠状动脉CTA的解剖学评估和动态CTP的功能评估相结合，可以更准确地识别具有血流动力学意义的CAD。

JACC：冠脉CTA可排除有临床意义的非ST段抬高型心梗患者

对于非ST段抬高型急性冠脉综合征（NSTEACS）患者，冠脉的病理解剖从结构正常血管到严重的冠脉损伤不等。本研究的目的旨在评估冠状动脉ct血管造影（CTA）是否能排除冠脉狭窄≥50%的NSTEACS患者。本研究纳入分析了接受冠脉CTA检查的1023名NSTEACS患者（其中583名在发病后12h内接受了冠脉CTA检查，440名在发病后48-72h内接受了冠脉CTA检查）。通过冠脉CTA，共发现了6

Radiology：SPECT灌注成像和冠脉CTA提示心脏会不会撂担子

本研究旨在验证联合SPECT心肌灌注（MPI）和冠脉CTA作为心脏影像学检查手段预测长期主要不良心脏事件（死亡、心肌梗死[MI]、不稳定心绞痛、冠脉血运重建）（MACEs）的价值。

Eur Radiol：冠心病患者福音--通过冠脉CTA随访预测远期风险！

本研究旨在利用冠状动脉CT血管造影（CCTA）评价稳定性心绞痛患者冠状动脉粥样硬化斑块负荷进展的预测价值，并探究其与主要心血管事件（MACE）发生率的相关性，并将结果发表在Eur Radiol上。